OUR PRIORITY IS YOU | Click here for COVID-19 updates

Intermed Labs at Mon Health Studio Joins Global Startup Studio Network, Opens New Doors for Entrepreneurial Growth in WV

Posted Date: 12/7/2020

Morgantown-based medtech startup studio, Intermed Labs at Mon Health, has joined the Global Startup Studio Network (GSSN), a tightly-knit group of the world's top venture building studios. GSSN connects innovators from member studios in Dubai, Palo Alto, Paris and Morgantown in order to increase access to operational processes, human and financial capital. Visit www.gssn.co for additional information about this community. 

Launched in 2020, Intermed Labs at Mon Health offers a platform for aspiring entrepreneurs within West Virginia's vibrant healthcare ecosystem to transform innovative medical ideas into viable businesses. Intermed Labs plays a crucial role in improving the human condition by providing critical venture-building infrastructure, talent, capital and expertise.

"Becoming a GSSN Studio is an incredible honor for our team and region," said Dr. Tom McClellan, co-founder of the venture, along with Ashok Aggarwal and Dr. Justin Chambers. "Intermed Labs at Mon Health is the only GSSN member within Appalachia and now part of a global organization of top innovators. . We are excited to share and collaborate on medtech innovations that can improve patient care and outcomes."

According to David Goldberg, President & CEO of Mon Health System, the acceptance of this startup studio into GSSN opens new doors for those who take part in the medtech enterprise's mission and will immediately advance innovation, improve patient outcomes, create jobs and economic opportunities in the local community and across West Virginia.

In the last five years, the Intermed Labs team has launched three new medical devices, with new prototypes and ideas in the works thanks to the medtech studio's launch. Acceptance into GSSN creates additional opportunities for medical entrepreneurs to share ideas, pioneer new concepts and make a positive impact.

"Intermed Labs is using their unique expertise to disrupt a legacy industry and share with health systems across the globe," said Nick Zasowski, Director of GSSN. "The work they are doing will drive more efficient growth, and we see their studio model as the future standard in medical device innovation."

This record has been viewed 1109 times.